Bestech Biotech Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 24-10-2024
- Paid Up Capital ₹ 0.10 M
as on 24-10-2024
- Company Age 13 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 16.13%
(FY 2023)
- Profit 7.87%
(FY 2023)
- Ebitda 169.95%
(FY 2023)
- Net Worth 20.85%
(FY 2023)
- Total Assets -23.69%
(FY 2023)
About Bestech Biotech
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Harish Kumar and Vikas Anand serve as directors at the Company.
- CIN/LLPIN
U24100HR2011PTC042430
- Company No.
042430
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Mar 2011
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Faridabad, Haryana, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Bestech Biotech Private Limited offer?
Bestech Biotech Private Limited offers a wide range of products and services, including Adhesives, Glue and Sealants, Bonding Agents, Cleaning Liquids & Wipes, Cleaning Chemicals, Acrylic Sealants, PVC, LDPE, HDPE & Plastic Sheets, Floor Protector, Cement and Concrete, Concrete Admixture, Waterproof Paint.
Who are the key members and board of directors at Bestech Biotech?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Harish Kumar  | Director | 16-Mar-2011 | Current |
| Vikas Anand | Director | 24-Mar-2015 | Current |
Financial Performance of Bestech Biotech.
Bestech Biotech Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 16.13% increase. The company also saw a slight improvement in profitability, with a 7.87% increase in profit. The company's net worth Soared by an impressive increase of 20.85%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bestech Biotech?
In 2023, Bestech Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Bestech Technoengineering Services Private LimitedActive 12 years 4 monthsHarish Kumar is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Bestech Biotech?
Unlock and access historical data on people associated with Bestech Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bestech Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bestech Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
